Skip to main content

454 Q4 Revenues Topped Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Feb. 2.
1. CuraGen Shows That 454's Q4 Revenue Dipped 1.1 Percent, Not 16 Percent (from Feb. 1)
2. Illumina's Q4 Revenues Leap 163 Percent as Profits Soar (from Feb. 2)
3. Illumina Shares Slump 11 Percent After Firm Said '07 R&D Costs May Double Last Year's (from Feb. 2)
4. EU Sets Aside $650K to Hold Five Genomics Conferences in Europe (from Feb. 1)
5. Stratagene Says QPCR, Reagent Sales Will Drive 7-Percent Growth in Q4 Revenue (from Feb. 1)
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.